Stoke Therapeutics, Inc. · NASDAQ:STOK

FMR LLC reported a 8.50% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 6, 2026

FMR LLC reported a 8.50% stake in Stoke Therapeutics, Inc., 5,313,100 shares, as a passive investor on Jun 30, 2026. Filed Aug 6, 2026 (Schedule 13G/A).

Stake
8.50%
Shares
5,313,100
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC8.50%5,313,100
Abigail P. Johnson8.50%5,313,100

Source

View original at SEC

Related